Literature DB >> 6088614

Lung tissue receptors for sulfidopeptide leukotrienes.

F A Kuehl, R N DeHaven, S S Pong.   

Abstract

Studies of the binding of tritiated sulfidopeptide leukotrienes (LTs) to a membrane preparation from rat lung tissue revealed a site specific for LTC4 with a dissociation constant of 4.1 X 10(-8)M. Similar experiments with a guinea pig lung preparation demonstrated binding specific for LTD4 with a dissociation constant of 2.1 X 10(-10)M. The divalent cations Ca++, Mg++, and Mn++ significantly enhanced the affinity of binding of the respective LTs to both sites. The binding of LTC4 to guinea pig lung and rat lung exhibited similar characteristics, but the former was observed only in the presence of the gamma-glutamyl transpeptidase inhibitor, serineborate complex. The binding affinities of various isomers of both sulfidopeptide LTs paralleled the potency of their pharmacologic effects, which supports the contention that the sites are receptors specific for LTC4 and LTD4. The slow-reacting substance of anaphylaxis antagonist, FPL 55712, had a higher affinity for the LTD4 receptor, which is consistent with its more effective antagonism of the LTD4-induced contractile response of guinea pig lung parenchymal strips. The ability of Na+ and guanosine triphosphate to inhibit the binding of LTD4 suggests that the action of LTD4 is associated with a depression of intracellular concentrations of cyclic adenosine monophosphate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088614     DOI: 10.1016/0091-6749(84)90134-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.

Authors:  T C O'Shaughnessy; P Georgiou; K Howland; M Dennis; C H Compton; N C Barnes
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

2.  Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

Authors:  M K Albazzaz; K R Patel
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

Review 3.  Airway receptors.

Authors:  P J Barnes
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 4.  New developments concerning leukotriene antagonists: a review.

Authors:  J H Musser; A F Kreft; A J Lewis
Journal:  Agents Actions       Date:  1986-06

5.  Immunopathogenetic roles of leukotrienes in human diseases.

Authors:  E J Goetzl; D G Payan; D W Goldman
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

Review 6.  Generation and recognition of leukotriene mediators of hypersensitivity and inflammation.

Authors:  E J Goetzl; B A Burrall; L Baud; K H Scriven; J D Levine; C H Koo
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.